6449|770|Public
5|$|Another {{clinical}} {{and public health}} concern is the proliferation of substandard <b>antimalarial</b> medicines resulting from inappropriate concentration of ingredients, contamination with other drugs or toxic impurities, poor quality ingredients, poor stability and inadequate packaging. A 2012 study demonstrated that roughly one-third of <b>antimalarial</b> medications in Southeast Asia and Sub-Saharan Africa failed chemical analysis, packaging analysis, or were falsified.|$|E
5|$|Malaria {{is treated}} with <b>antimalarial</b> medications; the ones used {{depends on the}} type and {{severity}} of the disease. While medications against fever are commonly used, their effects on outcomes are not clear.|$|E
5|$|Drug-induced {{psoriasis}} {{may occur}} with beta blockers, lithium, <b>antimalarial</b> medications, non-steroidal anti-inflammatory drugs, terbinafine, calcium channel blockers, captopril, glyburide, granulocyte colony-stimulating factor, interleukins, interferons, lipid-lowering drugs, and paradoxically TNF inhibitors such as infliximab or adalimumab. Withdrawal of corticosteroids (topical steroid cream) can aggravate psoriasis {{due to the}} rebound effect.|$|E
40|$|Objective In Africa <b>antimalarials</b> {{are often}} {{prescribed}} when malaria is unlikely, {{a problem that}} is becoming critical as more expensive <b>antimalarials</b> replace established drugs. However, {{little is known about}} what drives the overuse of <b>antimalarials.</b> We conducted this study to explore to what extent current prescribing behaviour in hospitals is driven by patient demand. Methods Consultations were observed followed by exit interviews with patients or caretakers. Five district hospitals where microscopy was routinely available were selected in areas of low (n 3) and high (n 2) malaria transmission in north-eastern Tanzania. All outpatient consultations during the study period were observed (n 669). Those sent for a malaria blood slide or treated with <b>antimalarials</b> presumptively were interviewed (n 326). At the end of the study, clinicians were interviewed for their opinions on the use of <b>antimalarials.</b> Findings Patients were not observed to demand <b>antimalarials</b> from clinicians, but occasionally asked for a malaria slide. Patient satisfaction on exit was similar between those prescribed <b>antimalarials</b> and those not prescribed <b>antimalarials...</b>|$|R
40|$|Abstract. Many <b>antimalarials</b> sold in sub-Saharan Africa are poor-quality (falsified, substandard, or degraded), and {{the burden}} of disease caused by this problem is inadequately quantified. In this article, we {{estimate}} the number of under-five deaths caused by ineffective treatment of malaria associated with consumption of poor-quality <b>antimalarials</b> in 39 sub-Saharan countries. Using Latin hypercube sampling our estimates were calculated {{as the product of}} the number of private sector <b>antimalarials</b> consumed by malaria-positive children in 2013; the proportion of private sector anti-malarials consumed that were of poor-quality; and the case fatality rate (CFR) of under-five malaria-positive children who did not receive appropriate treatment. An estimated 122, 350 (interquartile range [IQR]: 91, 577 – 154, 736) under-five malaria deaths were associated with consumption of poor-quality <b>antimalarials,</b> representing 3. 75 % (IQR: 2. 81 – 4. 75 %) of all under-five deaths in our sample of 39 countries. There is considerable uncertainty surrounding our results because of gaps in data on case fatality rates and prevalence of poor-quality <b>antimalarials.</b> Our analysis highlights the need for further investigation into the distribution of poor-quality <b>antimalarials</b> and the need for stronger surveillance and regula-tory efforts to prevent the sale of poor-quality <b>antimalarials...</b>|$|R
40|$|BACKGROUND: Development of {{resistance}} to first line <b>antimalarials</b> led to recommendation of artemisinin based combination therapies (ACTs). High adherence to ACTs provided by community health workers (CHWs) gave reassurance that community based interventions did not {{increase the risk of}} drug resistance. Integrated community case management of illnesses (ICCM) is now recommended through which children will access both antibiotics and <b>antimalarials</b> from CHWs. Increased number of medicines has been shown to lower adherence. OBJECTIVE: To compare adherence to <b>antimalarials</b> alone versus <b>antimalarials</b> combined with antibiotics under ICCM in children less than five years. METHODS: A cohort study was nested within a cluster randomized trial that had CHWs treating children less than five years with <b>antimalarials</b> and antibiotics (intervention areas) and CHWs treating children with <b>antimalarials</b> only (control areas). Children were consecutively sampled from the CHWs' registers in the control areas (667 children); and intervention areas (323 taking <b>antimalarials</b> only and 266 taking <b>antimalarials</b> plus antibiotics). The sampled children were visited at home on day one and four of treatment seeking. Adherence was assessed using self reports and pill counts. RESULTS: Adherence in the intervention arm to <b>antimalarials</b> alone and <b>antimalarials</b> plus antibiotics arm was similar (mean 99 % in both groups) but higher than adherence in the control arm (<b>antimalarials</b> only) (mean 96 %). Forgetfulness (38 %) was the most cited reason for non-adherence. At adjusted analysis: absence of fever (OR = 3. 3, 95 %CI = 1. 6 - 6. 9), seeking care after two or more days (OR = 2. 2, 95 %CI = 1. 3 - 3. 7), not understanding instructions given (OR = 24. 5, 95 %CI = 2. 7 - 224. 5), vomiting (OR = 2. 6, 95 %CI = 1. 2 - 5. 5), and caregivers' perception that the child's illness was not severe (OR = 2. 0, 95 %CI = 1. 1 - 3. 8) were associated with non-adherence. CONCLUSIONS: Addition of antibiotics to <b>antimalarials</b> did not lower adherence. However, caregivers should be adequately counseled to understand the dosing regimens; continue with medicines even when the child seems to improve; and re-administer doses that have been vomited...|$|R
5|$|In 1891, Paul Guttmann and Ehrlich {{noted that}} {{methylene}} blue {{had a high}} affinity for some tissues and that this dye had a slight <b>antimalarial</b> property. Methylene blue and its congeners may act by preventing the biocrystallization of heme.|$|E
5|$|In 1953, the World Health Organization (WHO) {{launched}} an <b>antimalarial</b> program {{in parts of}} Liberia as a pilot project to determine the feasibility of malaria eradication in tropical Africa. However, these projects encountered difficulties that foreshadowed the general retreat from malaria eradication efforts across tropical Africa by the mid-1960s.|$|E
5|$|In {{areas where}} malaria is common, {{children}} under {{five years old}} often have anemia which is sometimes due to malaria. Giving children with anemia in these areas preventive <b>antimalarial</b> medication improves red blood cell levels slightly but {{did not affect the}} risk of death or need for hospitalization.|$|E
40|$|<b>Antimalarials</b> {{are widely}} used in African and Southeast Asian countries, where they are {{combined}} with other drugs {{for the treatment of}} concurrent ailments. The potential for P-glycoprotein (P-gp) -mediated drug-drug interactions (DDIs) between <b>antimalarials</b> and P-gp substrates was examined using a Caco- 2 cell-based model. Selected <b>antimalarials</b> were initially screened for their interaction with P-gp based on the inhibition of rhodamine- 123 (Rho- 123) transport in Caco- 2 cells. Verapamil (100 mM) and quinidine (1 mM) were used as positive inhibition controls. Lumefantrine, amodiaquin, and artesunate all showed blockade of Rho- 123 transport. Subsequently, the inhibitory effect of these <b>antimalarials</b> on the bi-directional passage of digoxin (DIG) was examined. All of the drugs decreased basal-toapical (B-A) P-gp-mediated DIG transport at concentrations of 100 mM and 1 mM. These concentrations may reflect therapeutic doses for amodiaquin and artesunate. Therefore, clinically relevant DDIs may occur between certain <b>antimalarials</b> and P-gp substrates in general...|$|R
40|$|Abstract. We used an {{in vitro}} isotopic drug {{sensitivity}} assay {{to assess the}} sensitivity of Plasmodium falciparum isolates collected in Bangui, Central African Republic between March and July 2004. We tested <b>antimalarials</b> that are currently in use in this country (chloroquine, amodiaquine, quinine, and pyrimethamine), <b>antimalarials</b> that will become available in this region in the future (artemisinin and halofantrine), and prophylactic <b>antimalarials</b> (mefloquine, doxy-cycline, and atovaquone). The proportions of resistant isolates were 37 % for chloroquine, 15. 9 % for amodiaquine, 0...|$|R
40|$|In recent years, {{the use of}} {{a number}} of drugs, {{including}} antibiotics and <b>antimalarials,</b> which have undesirable tastes, has been increasing. Although <b>antimalarials</b> are widely administered parenterally, oral administration is more convenient and acceptable to pa-tients. Oral administration of <b>antimalarials,</b> especially to children, is often hampered by their unpleasant bitter taste. This leads to non-compliance and hinders therapeutic ma-nagement. Artemether (ARM), a drug used for treatment of malaria, has an extremely unpleas-ant bitter taste. The exact mechanism of bitterness is unknown. However, it has been re...|$|R
5|$|Louis Fieser – {{organic chemist}} and {{professor}} emeritus at Harvard University renowned as the inventor of a militarily effective form of napalm. His award-winning research included work on blood-clotting agents including the first synthesis of vitamin K, synthesis and screening of quinones as <b>antimalarial</b> drugs, work with steroids leading to the synthesis of cortisone, and study {{of the nature of}} polycyclic aromatic hydrocarbons.|$|E
5|$|With {{the onset}} of {{drug-resistant}} Plasmodium parasites, new strategies are being developed to combat the widespread disease. One such approach lies in the introduction of synthetic pyridoxal-amino acid adducts, which are {{taken up by the}} parasite and ultimately interfere with its ability to create several essential B vitamins. <b>Antimalarial</b> drugs using synthetic metal-based complexes are attracting research interest.|$|E
5|$|Extracts of Narcissus have {{demonstrated}} {{a number of}} potentially useful biological properties including antiviral, prophage induction, antibacterial, antifungal, <b>antimalarial,</b> insecticidal, cytotoxic, antitumor, antimitotic, antiplatelet, hypotensive, emetic, acetylcholine esterase inhibitory, antifertility, antinociceptive, chronotropic, pheromone, plant growth inhibitor, and allelopathic. An ethanol extract of Narcissus bulbs was found effective in one mouse model of nociception, para-benzoquinone induced abdominal constriction, but not in another, the hot plate test. Most of these properties are due to alkaloids, but some are also due to mannosa-binding lectins. The most-studied alkaloids in this group are galantamine (galanthamine), lycorine, narciclasine, and pretazettine.|$|E
40|$|Abstract. Widespread {{availability}} of monotherapies and falsified <b>antimalarials</b> {{is thought to}} have contributed to the historical development of multidrug-resistant malaria in Cambodia. This study aimed to document the quality of artemisinin-containing <b>antimalarials</b> (ACAs) and to compare two methods of collecting <b>antimalarials</b> from drug outlets: through open surveyors and mystery clients (MCs). Few oral artemisinin-based monotherapies and no suspected falsified medicines were found. All 291 samples contained the stated active pharmaceutical ingredient (API) of which 69 % were considered good quality by chemical analysis. Overall, medicine quality did not differ by collection method, although open surveyors were less likely to obtain oral artemisinin-based monotherapies thanMCs. The results are an encouraging indication of the positive impact of the country’s efforts to tackle falsified <b>antimalarials</b> and artemisinin-based mono-therapies. However, poor-quality medicines remain an ongoing challenge that demands sustained political will an...|$|R
40|$|Malaria is a {{major public}} health problem in the endemic {{countries}} of Africa, Asia and Latin America. Poor quality <b>antimalarials</b> are of major, but neglected, concern in the control of Plasmodium falciparum malaria. They cause treatment failure and economic loss, and engender drug resistance and loss of confidence in health systems. The emergence {{of resistance to the}} artemisinin derivatives in Asia bodes ill for malaria control in Africa, and strenuous efforts are needed {{to improve the quality of}} the world's supply of <b>antimalarials.</b> This article reviews the problem and discusses methods available to determine the quality of <b>antimalarials.</b> © 2010 Future Medicine Ltd...|$|R
40|$|Malaria {{remains a}} disease of public health concern, which is {{associated}} with high mortality and morbidity, particularly in sub-Saharan Africa. This picture is mainly due to low effectiveness of <b>antimalarials</b> at the community level, a scenario caused by different factors related to the availability, quality, and efficacy of <b>antimalarials</b> {{as well as the}} degree of the patients’ and providers’ adherence to evidence-based recommendations about malaria treatment. This review presents an overview of the problem of low community effectiveness of <b>antimalarials</b> in sub-Saharan Africa, with a focus on the various causes as well as potential strategies to combat the problem...|$|R
5|$|Given with {{chloroquine}} or quinine, clindamycin {{is effective}} and well tolerated in treating Plasmodium falciparum malaria; the latter combination is particularly useful for children, {{and is the}} treatment of choice for pregnant women who become infected in areas where resistance to chloroquine is common. Clindamycin {{should not be used}} as an <b>antimalarial</b> by itself, although it appears to be very effective as such, because of its slow action. Patient-derived isolates of Plasmodium falciparum from the Peruvian Amazon have been reported to be resistant to clindamycin as evidenced by in vitro drug susceptibility testing.|$|E
5|$|In 1834, in British Guiana, a German physician, Carl Warburg, invented an {{antipyretic}} medicine: 'Warburg's Tincture'. This secret, proprietary remedy contained quinine {{and other}} herbs. Trials {{were made in}} Europe in the 1840s and 1850s. It was officially adopted by the Austrian Empire in 1847. It was considered by many eminent medical professionals {{to be a more}} efficacious <b>antimalarial</b> than quinine. It was also more economical. The British Government supplied Warburg's Tincture to troops in India and other colonies.|$|E
5|$|In {{medicine}} and chemistry, SRI developed dry-powder drugs, laser photocoagulation (a treatment for some eye maladies), remote surgery (also known as telerobotic surgery), bio-agent detection using upconverting phosphor technology, the experimental anticancer drugs Tirapazamine and TAS-108, ammonium dinitramide (an environmentally benign oxidizer for safe and cost-effective disposal of hazardous materials), the electroactive polymer ("artificial muscle"), new uses for diamagnetic levitation, and the <b>antimalarial</b> drug Halofantrine.|$|E
40|$|Abstract: From 1963 to the present, many {{reviews of}} <b>antimalarials</b> {{for use in}} {{dermatology}} have mentioned the speeial sensitivity of ehildren to these drugs. Fatal reactions have been limited to aeeidental or intentional overdosage and two instanees of IM injection. While 1 gni of ehloroquine ean produee fatal reaetion in very young ehildren. analysis of published and unpublished eases show that adults exhibit a similar sensitivity when eompared on a mg/kg basis. This infor-mation should eneourage a physician to use <b>antimalarials</b> where appropriate, but speeial precaution {{should be taken to}} prevent poisoning. <b>Antimalarials</b> (AM) are not commonly used in thc treatment of children with skin disease. There are, however, several situations in which AM may be most useful (1 - 6). Isaacson. Elgart. and Turner list over 15 conditions in which <b>antimalarials</b> may be of some therapeutic benefit (3). Of these, discoid lupus er and polymorphus light eruption oecu...|$|R
40|$|AIM: Self-medication with {{antibiotics}} and <b>antimalarials</b> occurs among {{the population in}} Ethiopian. We studied to estimate the prevalence of self-medication {{with antibiotics}} and <b>antimalarials</b> in Ethiopia and evaluate factors associated with self-medications. METHODS: A cross-sectional study was conducted on 405 households, selected from Silte Zone in South Ethiopia, using a random sampling technique by employing a pretested questionnaire. Data were analyzed using SPSS for windows version 16. 0. Chi-square {{test was used to}} observe the association of variables. RESULT: The prevalence of self-medication with antibiotics/ <b>antimalarials</b> in this study was 14. 5 %. Twenty seven (6. 7 %) participants were self medicated with antibiotics, 2. 7 % used <b>antimalarials</b> drugs while 21 (5. 2 %) used both. Level of monthly income and educational status significantly influence pattern of antibiotics and <b>antimalarials</b> self medication (P< 0. 05). The top three diseases that led to self medication in this study were headache (38. 5 %), fever (35. 9 %), and cough (14. 1 %). Among self-medicated antibiotics, Amoxicillin (13. 5 %) followed by Ciprofloxacin (8. 5 %) were the most commonly used class of drug. From <b>antimalarials</b> chloroquine (10. 1 %) were highly abused. The main source of antibiotics /antimalarials was pharmacies (59. 0 %) followed by shops (Kiosks) (17. 9 %). The majority (20. 5 %) of the respondents practiced self medication to avoid waiting time at health facilities. CONCLUSION: The prevalence of self-medication with anti-biotic/ <b>antimalarials</b> in the study community was low. Self medication tended to be higher in people with a higher education and those on higher monthly incomes. The major reason for self-medication is found to be to avoid waiting time at health facility. Community pharmacies are the major source drugs. [TAF Prev Med Bull 2012; 11 (5. 000) : 529 - 536...|$|R
40|$|Chloroquine and {{mefloquine}} have superior safety {{profiles in}} pregnancy, though all <b>antimalarials</b> are effective for prophylaxis. <b>Antimalarials</b> will decrease {{the severity of}} maternal malaria infection and malaria-associated anemia, while decreasing the incidence of low birth weight and perinatal death in women having their first or second baby (strength of recommendation [SOR]: A, based on systematic review of consistent, good-quality patient-oriented evidence) ...|$|R
5|$|Recommended {{treatment}} for severe malaria is the intravenous use of <b>antimalarial</b> drugs. For severe malaria, parenteral artesunate {{was superior to}} quinine in both children and adults. In another systematic review, artemisinin derivatives (artemether and arteether) were as efficacious as quinine {{in the treatment of}} cerebral malaria in children. Treatment of severe malaria involves supportive measures that are best done in a critical care unit. This includes the management of high fevers and the seizures that may result from it. It also includes monitoring for poor breathing effort, low blood sugar, and low blood potassium.|$|E
5|$|The risk {{of disease}} {{can be reduced}} by {{preventing}} mosquito bites {{through the use of}} mosquito nets and insect repellents, or with mosquito control measures such as spraying insecticides and draining standing water. Several medications are available to prevent malaria in travellers to areas where the disease is common. Occasional doses of the combination medication sulfadoxine/pyrimethamine are recommended in infants and after the first trimester of pregnancy in areas with high rates of malaria. Despite a need, no effective vaccine exists, although efforts to develop one are ongoing. The recommended treatment for malaria is a combination of <b>antimalarial</b> medications that includes an artemisinin. The second medication may be either mefloquine, lumefantrine, or sulfadoxine/pyrimethamine. Quinine along with doxycycline may be used if an artemisinin is not available. It is recommended that in areas where the disease is common, malaria is confirmed if possible before treatment is started due to concerns of increasing drug resistance. Resistance among the parasites has developed to several <b>antimalarial</b> medications; for example, chloroquine-resistant P.falciparum has spread to most malarial areas, and resistance to artemisinin has become a problem in some parts of Southeast Asia.|$|E
5|$|The {{signs and}} {{symptoms}} of malaria typically begin 8–25 days following infection; however, symptoms may occur later in those who have taken <b>antimalarial</b> medications as prevention. Initial manifestations of the disease—common to all malaria species—are similar to flu-like symptoms, and can resemble other conditions such as sepsis, gastroenteritis, and viral diseases. The presentation may include headache, fever, shivering, joint pain, vomiting, hemolytic anemia, jaundice, hemoglobin in the urine, retinal damage, and convulsions.|$|E
40|$|Widespread {{availability}} of monotherapies and falsified <b>antimalarials</b> {{is thought to}} have contributed to the historical development of multidrug-resistant malaria in Cambodia. This study aimed to document the quality of artemisinin-containing <b>antimalarials</b> (ACAs) and to compare two methods of collecting <b>antimalarials</b> from drug outlets: through open surveyors and mystery clients (MCs). Few oral artemisinin-based monotherapies and no suspected falsified medicines were found. All 291 samples contained the stated active pharmaceutical ingredient (API) of which 69 % were considered good quality by chemical analysis. Overall, medicine quality did not differ by collection method, although open surveyors were less likely to obtain oral artemisinin-based monotherapies than MCs. The results are an encouraging indication of the positive impact of the country's efforts to tackle falsified <b>antimalarials</b> and artemisinin-based monotherapies. However, poor-quality medicines remain an ongoing challenge that demands sustained political will and investment of human and financial resources. 2015 - 06 - 03 T 00 : 00 : 00...|$|R
40|$|Background The World Health Organisation {{currently}} {{recommends the}} use of artemisinin-based combination drugs for treatment of uncomplicated malaria in high malaria endemic regions. However, comprehensive understanding of factors affecting treatment of malaria with <b>antimalarials</b> is lacking in many rural communities in Africa. This study seeks to test the following hypothesise: 1. That socio-economic and demographic factors at the household level affect treatment of self reported malaria/fever with <b>antimalarials</b> in the Kilombero/Ulanga and Rufiji valleys in Tanzania 2. Distance of a household to a health facility affects treatment of malaria/fever with <b>antimalarials</b> in the Kilombero/Ulanga and Rufiji valleys in Tanzania. Methods: Secondary data analysis of a cross- sectional household survey on <b>antimalarials</b> carried out in 2005 in the Kilombero/Ulanga and Rufiji valleys in Tanzania. Georeferenced health facilities and households’ datasets from the Rufiji and Ifakara demographic surveillance systems sites were also used to estimate distance variables. Results: Out {{of a total of}} 1433 participants who reported malaria/fever, 32...|$|R
5000|$|... #Caption: Hemozoin {{formation}} in P. falciparum: many <b>antimalarials</b> are strong inhibitors of hemozoin crystal growth.|$|R
5|$|Between 1937 and 1938, Bishop {{studied the}} effects of various factors, {{including}} different substances in blood and different temperatures, on the feeding behaviour of the chicken malaria (Plasmodium gallinaceum) vector, Aedes aegypti. She also examined factors that contributed to Plasmodium reproduction. This work {{became the basis for}} subsequent ongoing research into a malaria vaccine. Her subsequent work was spurred by the outbreak of the Second World War. During the war, she investigated alternative chemotherapies for malaria. Her research aided the British war effort because the most prevalent <b>antimalarial,</b> quinine, was difficult to obtain due to the Japanese occupation of the Dutch West Indies. From 1947 to 1964, she {{was in charge of the}} Institute's Chemotherapy Research Institute, associated with the Medical Research Council.|$|E
5|$|Drug {{resistance}} poses {{a growing}} problem in 21st-century malaria treatment. Resistance is now common against all classes of <b>antimalarial</b> drugs apart from artemisinins. Treatment of resistant strains became increasingly dependent on this class of drugs. The cost of artemisinins limits their use in the developing world. Malaria strains found on the Cambodia–Thailand border are resistant to combination therapies that include artemisinins, and may, therefore, be untreatable. Exposure of the parasite population to artemisinin monotherapies in subtherapeutic doses for over 30 years {{and the availability of}} substandard artemisinins likely drove the selection of the resistant phenotype. Resistance to artemisinin has been detected in Cambodia, Myanmar, Thailand, and Vietnam, and there has been emerging resistance in Laos.|$|E
5|$|Bishop's work {{evolved to}} include studies of drug {{resistance}} {{in both the}} parasites and the host organisms, the studies that would earn her {{a place in the}} Royal Society. Significant work from this period of Bishop's life included a study showing that the parasite itself did not develop resistance to quinine, but that host organisms could develop resistance to the drug proguanil. Her in vitro research was proven accurate when the drugs she studied were used to treat patients suffering from tertian malaria, a form of the illness in which the paroxysm of fever occurs every third day. She also investigated the drugs pamaquine and atebrin, along with proguanil, though proguanil was the only one shown to cause the development of drug resistance. Other studies showed that malaria parasites could develop cross-resistance to other <b>antimalarial</b> drugs. Bishop worked at Molteno until 1967. Her research and experimental protocols were later used in rodent and human studies, albeit with modifications.|$|E
5000|$|... antibiotics, antifungals, antileprotics, {{antituberculous}} drugs, <b>antimalarials,</b> anthelmintics, amoebicides, antivirals, antiprotozoals, probiotics, prebiotics, antitoxins and antivenoms.|$|R
40|$|Plasmodium {{falciparum malaria}} is {{increasing}} world-wide, as is {{resistance to the}} available <b>antimalarials.</b> On the Thai-Burmese border this problem is most acute in pregnant women, as options for their treatment are even more restricted because of the unknown effects of <b>antimalarials</b> on the foetus. Presented here are the results of descriptive, clinical, drug studies on quinine, mefloquine and artemisinin derivatives for P. falciparum in pregnant women. Mefloquine and quinine have high failure rates for primary and recrudescent infections. Artemisinin-based treatments in pregnant women have proved safe, tolerable and efficacious. However, randomized drug studies with these drugs and other new <b>antimalarials</b> are required to define the true safety and efficacy of these drugs in pregnant women...|$|R
40|$|ABSTRACT. Purpose: To {{estimate}} {{the prevalence of}} self medication with antibiotics and <b>antimalarials</b> in Khartoum State, Sudan and evaluate factors associated with self medication. Methods: A pre-tested questionnaire was used to collect data from a sample of 600 households, (1750 adult persons), selected from three cities in Khartoum State, Sudan, using a multistage stratified clustered sampling. Results: One thousand two hundred and ninety three (73. 9 %) of the study population had used antibiotics or <b>antimalarials</b> without a prescription within one month prior to the study. Eight hundred and forty one (48. 1 %) of the respondents agreed that they have used antibiotics, 43. 4 % used <b>antimalarials,</b> while 17. 5 % used both. Self medication with eithe...|$|R
